JP2021528459A - 糖尿病の治療におけるマンヌロン二酸組成物の使用 - Google Patents

糖尿病の治療におけるマンヌロン二酸組成物の使用 Download PDF

Info

Publication number
JP2021528459A
JP2021528459A JP2020572806A JP2020572806A JP2021528459A JP 2021528459 A JP2021528459 A JP 2021528459A JP 2020572806 A JP2020572806 A JP 2020572806A JP 2020572806 A JP2020572806 A JP 2020572806A JP 2021528459 A JP2021528459 A JP 2021528459A
Authority
JP
Japan
Prior art keywords
total weight
composition
acid
mannuronedioic
diacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528459A5 (https=
JPWO2020001644A5 (https=
Inventor
ゲン、メイユ
シン、シャンリャン
チャン、チェンチン
ディン、ジャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Shanghai Green Valley Pharmaceutical Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Publication of JP2021528459A publication Critical patent/JP2021528459A/ja
Publication of JP2021528459A5 publication Critical patent/JP2021528459A5/ja
Publication of JPWO2020001644A5 publication Critical patent/JPWO2020001644A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2020572806A 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528459A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810721304.5 2018-06-29
CN201810721304.5A CN110652526A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗糖尿病中的应用
PCT/CN2019/093822 WO2020001644A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗糖尿病中的应用

Publications (3)

Publication Number Publication Date
JP2021528459A true JP2021528459A (ja) 2021-10-21
JP2021528459A5 JP2021528459A5 (https=) 2022-07-04
JPWO2020001644A5 JPWO2020001644A5 (https=) 2022-07-04

Family

ID=68985883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572806A Pending JP2021528459A (ja) 2018-06-29 2019-06-28 糖尿病の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406652B2 (https=)
EP (1) EP3815690A4 (https=)
JP (1) JP2021528459A (https=)
KR (1) KR20210038875A (https=)
CN (1) CN110652526A (https=)
AU (1) AU2019296855A1 (https=)
WO (1) WO2020001644A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336742A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530718A (ja) * 2004-03-24 2007-11-01 中国海洋大学 アルギンオリゴ糖及びその誘導体、並びにそれらの調製と用途
WO2018032272A1 (zh) * 2016-08-15 2018-02-22 上海绿谷制药有限公司 低聚甘露糖醛二酸的制备方法
WO2018121559A1 (zh) * 2016-12-30 2018-07-05 上海绿谷制药有限公司 甘露糖醛二酸的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
CN100508985C (zh) * 2004-03-24 2009-07-08 中国海洋大学 褐藻胶寡糖及其衍生物及其制备方法和用途
CN101889027B (zh) 2007-12-29 2013-05-01 于传兴 低分子量海藻酸及其盐、应用、制法及药物组合物、食品
KR20160116252A (ko) 2015-03-27 2016-10-07 전남대학교산학협력단 비환원성 말단의 불포화형 만뉴론산 올리고당 및 이를 유효성분으로 포함하는 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530718A (ja) * 2004-03-24 2007-11-01 中国海洋大学 アルギンオリゴ糖及びその誘導体、並びにそれらの調製と用途
WO2018032272A1 (zh) * 2016-08-15 2018-02-22 上海绿谷制药有限公司 低聚甘露糖醛二酸的制备方法
WO2018121559A1 (zh) * 2016-12-30 2018-07-05 上海绿谷制药有限公司 甘露糖醛二酸的组合物

Also Published As

Publication number Publication date
US20210322449A1 (en) 2021-10-21
WO2020001644A1 (zh) 2020-01-02
KR20210038875A (ko) 2021-04-08
CN110652526A (zh) 2020-01-07
US11406652B2 (en) 2022-08-09
EP3815690A1 (en) 2021-05-05
AU2019296855A1 (en) 2021-01-28
EP3815690A4 (en) 2022-04-13

Similar Documents

Publication Publication Date Title
KR102539060B1 (ko) 만누론 이산의 조성물
JP6900414B2 (ja) 酸化型β−１，４−グルクロン酸オリゴマーおよびその製造方法と使用
US11406659B2 (en) Use of mannuronic diacid composition in treatment of inflammation
US11406652B2 (en) Use of mannuronic diacid composition in treatment of diabetes
US11406654B2 (en) Use of mannuronic diacid composition in treatment of Parkinson's disease
HK40016250A (en) Use of a composition of mannuronic diacids in the treatment of diabetes
US11406653B2 (en) Use of mannuronic diacid composition in treatment of pain
US11406651B2 (en) Use of mannuronic diacid composition in treatment of vascular dementia
HK40014917A (en) Use of a composition of oligomeric mannuronic diacid for treating parkinson's disease
JP2022543641A (ja) Ｔｈ１優位関連疾患の治療におけるマンヌロン酸オリゴ糖またはそれを含んでなる組成物の使用
HK40014915A (en) Use of a composition of oligomeric mannuronic diacid for treating inflammation
HK40016251A (en) Use of a composition of mannuronic diacids in the treatment of pain

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230519

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230524

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231212